Status:
WITHDRAWN
Effect of Non-pharmacological Therapy on Cognitive Function of Patients With Cognitive Impairment
Lead Sponsor:
National Institute of Medical Sciences and Nutrition, Salvador Zubiran
Conditions:
Mild Cognitive Impairment
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
Supervised nonpharmacologic therapy improve cognitive function in patients with Mild Cognitive Impairment
Eligibility Criteria
Inclusion
- Patients 60 years and older with Mild Cognitive Impairment according to Petersen Criteria
- Phone number available
Exclusion
- Untreated depression
- Evidence of a reversible cause of cognitive decline
- Dementia of any type and stage
- Severe sensory deficit unresolved
- Metastatic cancer
- Hemoglobin level \< 8g/dL
- Chronic Obstructive Pulmonary Disease Gold stage 3 or 4
- Congestive Heart Failure decompensated, unstable angina o Functional Class IV according to New York Heart Association
- Participation in another protocol that prevents its participation in this research
- Chronic use of benzodiazepines, tricyclic antidepressants
- Patients whose place of residence can not attend the sessions
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01819623
Last Update
April 22 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institue of Medical Sciences and Nutrition Salvador Zubirán
Mexico City, Mexico City, Mexico, 14000